erlotinib has been researched along with combretastatin a-4 disodium phosphate in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (combretastatin a-4 disodium phosphate) | Trials (combretastatin a-4 disodium phosphate) | Recent Studies (post-2010) (combretastatin a-4 disodium phosphate) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 43 | 0 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Baraldi, S; Bortolozzi, R; Brancale, A; Chayah, M; Ferla, S; Hamel, E; Kimatrai Salvador, M; Lopez-Cara, LC; Mariotto, E; Mattiuzzo, E; Oliva, P; Prencipe, F; Romagnoli, R; Ronca, R; Schiaffino Ortega, S; Viola, G | 1 |
1 other study(ies) available for erlotinib and combretastatin a-4 disodium phosphate
| Article | Year |
|---|---|
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Design; Drug Evaluation, Preclinical; Enzyme Activation; ErbB Receptors; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Microtubules; Poly(ADP-ribose) Polymerases; Polymerization; Pyrimidines; Reactive Oxygen Species; Tubulin; Vascular Endothelial Growth Factor Receptor-2 | 2019 |